title: Octreotide treatment for chylothorax after congenital heart surgery.
authors.forename: Vedide
authors.initials: V
authors.lastname: Tavli
authors.forename: Murat M
authors.initials: MM
authors.lastname: Yilmazer
authors.forename: Bariş
authors.initials: B
authors.lastname: Guven
authors.forename: Timur
authors.initials: T
authors.lastname: Mese
authors.forename: Banu
authors.initials: B
authors.lastname: Lafci
authors.forename: Ali
authors.initials: A
authors.lastname: Gurbuz
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D002675:Child, Preschool; D002916:Chylothorax / Q000188:drug therapy* / Q000209:etiology; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006330:Heart Defects, Congenital / Q000601:surgery*; D006801:Humans; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D005765:Gastrointestinal Agents; D015282:Octreotide